Literature DB >> 16184032

Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study.

Cristina Mussini1, Marcello Pinti, Roberto Bugarini, Vanni Borghi, Milena Nasi, Elisa Nemes, Leonarda Troiano, Giovanni Guaraldi, Andrea Bedini, Caroline Sabin, Roberto Esposito, Andrea Cossarizza.   

Abstract

BACKGROUND: HIV infection per se and HAART can alter mitochondrial functionality, leading to a decrease in mitochondrial DNA content.
OBJECTIVE: To evaluate whether treatment interruption monitored by CD4 cell count can restore mitochondrial DNA content in peripheral blood lymphocytes.
METHODS: Mitochondrial DNA content was measured in platelet-free CD4 and CD8 T cells by real-time polymerase chain reaction; flow cytometry was used to identify and quantify activated CD4 and CD8 T lymphocytes.
RESULTS: The 30 patients had been treated for a mean of 107 months (range, 27-197). Median CD4 cell count at discontinuation was 702 cells/microl (range, 547-798). Median observational time from HAART discontinuation was 11.3 months (range, 4-26). Discontinuation of treatment provoked significant increases in mitochondrial DNA in CD8 T cells, which started only 6 months after therapy discontinuation [5.12 copies/cell per month from 0 to 6 months (P = 0.37) and 26.96 copies/cell per month from 6 to 12 months (P < 0.0001)].
CONCLUSIONS: This study is the first showing that mitochondrial DNA content can increase in peripheral blood lymphocytes during treatment interruption, but only after at least 6 months of interruption. Consequently, interruptions of shorter periods, whether by clinician or patient decision, are unlikely to allow restoration of mitochondrial DNA and so decrease HAART-related toxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16184032     DOI: 10.1097/01.aids.0000186019.47297.0d

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder.

Authors:  Valentina Del Dotto; Farid Ullah; Ivano Di Meo; Pamela Magini; Mirjana Gusic; Alessandra Maresca; Leonardo Caporali; Flavia Palombo; Francesca Tagliavini; Evan Harris Baugh; Bertil Macao; Zsolt Szilagyi; Camille Peron; Margaret A Gustafson; Kamal Khan; Chiara La Morgia; Piero Barboni; Michele Carbonelli; Maria Lucia Valentino; Rocco Liguori; Vandana Shashi; Jennifer Sullivan; Shashi Nagaraj; Mays El-Dairi; Alessandro Iannaccone; Ioana Cutcutache; Enrico Bertini; Rosalba Carrozzo; Francesco Emma; Francesca Diomedi-Camassei; Claudia Zanna; Martin Armstrong; Matthew Page; Nicholas Stong; Sylvia Boesch; Robert Kopajtich; Saskia Wortmann; Wolfgang Sperl; Erica E Davis; William C Copeland; Marco Seri; Maria Falkenberg; Holger Prokisch; Nicholas Katsanis; Valeria Tiranti; Tommaso Pippucci; Valerio Carelli
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

2.  Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy.

Authors:  Carla Giordano; Monica Montopoli; Elena Perli; Maurizia Orlandi; Marianna Fantin; Fred N Ross-Cisneros; Laura Caparrotta; Andrea Martinuzzi; Eugenio Ragazzi; Anna Ghelli; Alfredo A Sadun; Giulia d'Amati; Valerio Carelli
Journal:  Brain       Date:  2010-10-13       Impact factor: 13.501

Review 3.  The other genome: a systematic review of studies of mitochondrial DNA haplogroups and outcomes of HIV infection and antiretroviral therapy.

Authors:  Anna B Hart; David C Samuels; Todd Hulgan
Journal:  AIDS Rev       Date:  2013 Oct-Dec       Impact factor: 2.500

4.  Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion.

Authors:  Carla Giordano; Mariangela Sebastiani; Roberto De Giorgio; Claudia Travaglini; Andrea Tancredi; Maria Lucia Valentino; Marzio Bellan; Andrea Cossarizza; Michio Hirano; Giulia d'Amati; Valerio Carelli
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

Review 5.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

6.  Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.

Authors:  H Samji; T E Taha; D Moore; A N Burchell; A Cescon; C Cooper; J M Raboud; M B Klein; M R Loutfy; N Machouf; C M Tsoukas; J S G Montaner; R S Hogg
Journal:  HIV Med       Date:  2014-09-01       Impact factor: 3.180

7.  Pathological mitophagy disrupts mitochondrial homeostasis in Leber's hereditary optic neuropathy.

Authors:  Alberto Danese; Simone Patergnani; Alessandra Maresca; Camille Peron; Andrea Raimondi; Leonardo Caporali; Saverio Marchi; Chiara La Morgia; Valentina Del Dotto; Claudia Zanna; Angelo Iannielli; Alice Segnali; Ivano Di Meo; Andrea Cavaliere; Magdalena Lebiedzinska-Arciszewska; Mariusz R Wieckowski; Andrea Martinuzzi; Milton N Moraes-Filho; Solange R Salomao; Adriana Berezovsky; Rubens Belfort; Christopher Buser; Fred N Ross-Cisneros; Alfredo A Sadun; Carlo Tacchetti; Vania Broccoli; Carlotta Giorgi; Valeria Tiranti; Valerio Carelli; Paolo Pinton
Journal:  Cell Rep       Date:  2022-07-19       Impact factor: 9.995

8.  Mammalian RNase H1 directs RNA primer formation for mtDNA replication initiation and is also necessary for mtDNA replication completion.

Authors:  Jelena Misic; Dusanka Milenkovic; Ali Al-Behadili; Xie Xie; Min Jiang; Shan Jiang; Roberta Filograna; Camilla Koolmeister; Stefan J Siira; Louise Jenninger; Aleksandra Filipovska; Anders R Clausen; Leonardo Caporali; Maria Lucia Valentino; Chiara La Morgia; Valerio Carelli; Thomas J Nicholls; Anna Wredenberg; Maria Falkenberg; Nils-Göran Larsson
Journal:  Nucleic Acids Res       Date:  2022-08-10       Impact factor: 19.160

9.  Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure.

Authors:  Annalinda Pisano; Bruna Cerbelli; Elena Perli; Maria Pelullo; Valentina Bargelli; Carmela Preziuso; Massimiliano Mancini; Langping He; Matthew G D Bates; Joaquin R Lucena; Paola Lilla Della Monica; Giuseppe Familiari; Vincenzo Petrozza; Chiara Nediani; Robert W Taylor; Giulia d'Amati; Carla Giordano
Journal:  Cardiovasc Pathol       Date:  2015-09-30       Impact factor: 2.185

10.  Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death.

Authors:  Daniela Catanzaro; Edoardo Gaude; Genny Orso; Carla Giordano; Giulia Guzzo; Andrea Rasola; Eugenio Ragazzi; Laura Caparrotta; Christian Frezza; Monica Montopoli
Journal:  Oncotarget       Date:  2015-10-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.